Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases

American Journal of Gastroenterology

Volumn 103, Issue 1, 2008, Pages 138-146

  Wörns, Marcus A ^a   Teufel, Andreas ^a   Kanzler, Stephan ^a   Shrestha, Annette ^a   Victor, Anja ^a   Otto, Gerd ^a   Lohse, Ansgar W ^b   Galle, Peter R ^a   Höhler, Thomas ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c PROSPER HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; HEPATITIS A VACCINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC LIVER DISEASE; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION SENSITIVITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SUPERINFECTION; VACCINATION;

ADULT; ANTIBODIES, ANTINUCLEAR; DISEASE SUSCEPTIBILITY; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS, AUTOIMMUNE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; VACCINATION;

EID: 37849030761     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01609.x     Document Type: Article

References (47)

1. Lok AS. Chronic hepatitis B. N Engl J Med 2002 346 : 1682 3.
2. Lemon SM. Type A viral hepatitis: New developments in an old disease. N Engl J Med 1985 313 : 1059 67.
3. Dienstag JL, Isselbacher KJ. Acute hepatitis. In : Isselbacher KJ, Braunwald E, Wilson JD, et al. eds. Harrison's principles of internal medicine, Vol. 2, 13th Ed. New York : McGraw-Hill, 1994 : 1458 77.
4. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995 90 : 201 5.
5. Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In : Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore, MD : Lippincott, Williams & Wilkins, 1991 : 76 8.
6. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998 338 : 286 90.
7. Feray C, Gigou M, Samuel D, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993 104 : 549 55.
8. Krogsgaard K, Wantzin P, Mathiesen L, et al. Chronic evolution of acute hepatitis B: The significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme. Scand J Gastroenterol 1991 26 : 275 80.
9. Crespo J, Lozano JL, Carte B, et al. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur J Clin Microbiol Infect Dis 1997 16 : 445 51.
10. Crespo J, Lozano JL, de la Cruz F, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994 89 : 1147 51.
11. Zarski JP, Bohn B, Bastie A, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998 28 : 27 33.
12. Kaklamani E, Trichopoulos D, Tzonou A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991 265 : 1974 6.
13. Simonetti RG, Camma C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: A case-control study. Ann Intern Med 1992 116 : 97 102.
14. Public health control of hepatitis A: Memorandum from a WHO meeting. Bull World Health Organ 1995 73 : 15 20.
15. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 45 : 1 30.
16. Shim M, Khaykis I, Park J, et al. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination. Hepatology 2005 42 : 688 95.
17. Arguedas MR, McGuire BM, Fallon MB. Implementation of vaccination in patients with cirrhosis. Dig Dis Sci 2002 47 : 384 7.
18. Kiefer LA, Honish A, Predy G, et al. The seroprevalence of hepatitis A and B in people testing positive for hepatitis C. CMAJ 2000 162 : 207 8.
19. Kyrlagkitsis I, Cramp ME, Smith H, et al. Acute hepatitis A virus infection: A review of prognostic factors from 25 years experience in a tertiary referral center. Hepatogastroenterology 2002 49 : 524 8.
20. Hadler SC. Global impact of hepatitis A virus infection changing patterns. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore, MD : Lippincott, Williams & Wilkins, 1990 : 14 20.
21. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002 36 : 479 97.
22. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000 31 : 1005 13.
23. Cullen SN, Chapman RW. Review article: Current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 2005 21 : 933 48.
24. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 2001 33 : 994 1002.
25. Siddiqui F, Mutchnick M, Kinzie J, et al. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: Implications for vaccination strategy. Am J Gastroenterol 2001 96 : 858 63.
26. Keeffe EB, Iwarson S, McMahon BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998 27 : 881 6.
27. Lee SD, Chan CY, Yu MI, et al. Hepatitis B vaccination in patients with chronic hepatitis C. J Med Virol 1999 59 : 463 8.
28. Keeffe EB. Vaccination against hepatitis A and B in chronic liver disease. Viral Hepatitis Rev 1999 5 : 77 88.
29. Dumot JA, Barnes DS, Younossi Z, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999 94 : 1601 4.
30. Chalasani N, Smallwood G, Halcomb J, et al. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg 1998 4 : 128 32.
31. Wiedmann M, Liebert UG, Oesen U, et al. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000 31 : 230 4.
32. Rosman AS, Basu P, Galvin K, et al. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: A randomized clinical trial. Am J Med 1997 103 : 217 22.
33. Reiss G, Keeffe EB. Review article: Hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther 2004 19 : 715 27.
34. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989 321 : 708 12.
35. Craven DE, Awdeh ZL, Kunches LM, et al. Nonresponsiveness to hepatitis B vaccine in health care workers: Results of revaccination and genetic typings. Ann Intern Med 1986 105 : 356 60.
36. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: Multiple HLA genes are involved. Tissue Antigens 1998 51 : 593 604.
37. Hohler T, Stradmann-Bellinghausen B, Starke R, et al. C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol 2002 37 : 387 92.
38. Kruskall MS, Alper CA, Awdeh Z, et al. The immune response to hepatitis B vaccine in humans: Inheritance patterns in families. J Exp Med 1992 175 : 495 502.
39. Czaja AJ, Kruger M, Santrach PJ, et al. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol 1997 92 : 2197 200.
40. Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991 13 : 701 6.
41. Doherty DG, Underhill JA, Donaldson PT, et al. Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity 1994 18 : 243 9.
42. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991 101 : 1367 73.
43. Saab S, Lee C, Shpaner A, et al. Seroepidemiology of hepatitis A in patients with chronic liver disease. J Viral Hepat 2005 12 : 101 5.
44. Duncan M, Hirota WK, Tsuchida A. Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease: A prospective cost analysis. Am J Gastroenterol 2002 97 : 1792 5.
45. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997 113 : 1668 74.
46. Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 2001 1 : 185 91.
47. Holt D, Thomas R, Van Thiel D, et al. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002 137 : 572 5.